Our research group studies the immunologic and molecular mechanisms involved in the development of infections, inflammation and cancer within the gut.
Our research aims at a better understanding of the pathogenesis of these diseases on a molecular and cellular level. On the basis of these findings, we ultimately seek to develop novel therapeutic options for patients with inflammatory bowel disease or colon cancer. On the following web pages, you will find further information on our research group and our current projects.
We have a long standing experience in investigating the gut with molecular biological, cell biological and immunological techniques. A technological focus of our group is the performance and analysis of experimental disease models for intestinal inflammation, infection and cancer development. Furthermore, we have extensive experience in using endoscopic techniques in preclinical models and in the conditional mutagenesis of the gut using the Cre-Lox-model (Villin-Cre, Villin-CreERT2).
Collaborative research together with other research groups is particularly exciting. Requests for cooperation are always welcome.